Reaction

Serous Retinopathy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 103 reports · 4 co-occurring drugs

As of the last recalculation, Serous Retinopathy appears in 103 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is ENCORAFENIB (PRR 2,503.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Encorafenib562,503.42,517.7
Vemurafenib9165.7165.8
Trametinib12113.5113.5
Dabrafenib883.183.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.